End effector with implantable layer

US10064624B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10064624-B2
Application numberUS-201414549219-A
CountryUS
Kind codeB2
Filing dateNov 20, 2014
Priority dateSep 30, 2010
Publication dateSep 4, 2018
Grant dateSep 4, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An end effector for stapling patient tissue is disclosed. The end effector comprises a frame comprising a proximal end and a distal end, a plurality of staples, a firing system configured to implant the staples into the patient tissue, an implantable layer comprising a tissue-contacting surface and a support surface, and an array of securement members extending above and below the support surface of the implantable layer. The securement members are detached from the frame concurrently with the firing system being actuated to implant the staples.

First claim

Opening claim text (preview).

What is claimed is: 1. An end effector for stapling patient tissue, said end effector comprising: a frame comprising a proximal end and a distal end; a plurality of staples; a firing system configured to implant said staples into the patient tissue; an implantable layer comprising a tissue-contacting surface and a support surface; and an array of securement members extending above and below said support surface of said implantable layer, wherein said securement members are detached from said frame concurrently with said firing system being actuated to implant said staples. 2. The end effector of claim 1 , further comprising a cutting member movable from said proximal end toward said distal end to transect the patient tissue. 3. The end effector of claim 1 , wherein said firing system comprises: staple supports which support said staples when said firing system is actuated; and an anvil configured to deform said staples, wherein a first distance is defined between said staple supports and said anvil prior to said firing system being actuated, and wherein a second distance is defined between said staple supports and said anvil after said firing system has been actuated which is different than said first distance. 4. The end effector of claim 1 , wherein said staples comprise: a first longitudinal row of first staples having a first unfired height; and a second longitudinal row of second staples having a second unfired height which is different than said first unfired height. 5. An end effector for stapling patient tissue, said end effector comprising: a frame comprising a proximal end and a distal end; a plurality of staples; a firing system configured to implant said staples into the patient tissue; an implantable layer comprising a tissue-contacting surface and a bottom surface; and a plurality of retainers extending above and below said bottom surface of said implantable layer, wherein said retainers are released from said frame when said firing system is actuated to implant said staples. 6. The end effector of claim 5 , further comprising a cutting member movable from said proximal end toward said distal end to transect the patient tissue. 7. The end effector of claim 5 , wherein said firing system comprises: staple supports which support said staples when said firing system is actuated; and an anvil configured to deform said staples, wherein a first distance is defined between said staple supports and said anvil prior to said firing system being actuated, and wherein a second distance is defined between said staple supports and said anvil after said firing system has been actuated which is different than said first distance. 8. The end effector of claim 5 , wherein said staples comprise: a first longitudinal row of first staples having a first unfired height; and a second longitudinal row of second staples having a second unfired height which is different than said first unfired height. 9. An end effector for stapling patient tissue, said end effector comprising: a frame comprising a proximal end and a distal end; a plurality of staples; a firing system configured to implant said staples into the patient tissue; an implantable layer comprising a tissue-contacting surface and a bottom surface; and a plurality of securement members extending above and below said bottom surface of said implantable layer, wherein said securement members are mechanically disrupted when said firing system is actuated to implant said staples. 10. The end effector of claim 9 , further comprising a cutting member movable from said proximal end toward said distal end to transect the patient tissue. 11. The end effector of claim 9 , wherein said firing system comprises: staple supports which support said staples when said firing system is actuated; and an anvil configured to deform said staples, wherein a first distance is defined between said staple supports and said anvil prior to said firing system being actuated, and wherein a second distance is defined between said staple supports and said anvil after said firing system has been actuated which is different than said first distance. 12. The end effector of claim 9 , wherein said staples comprise: a first longitudinal row of first staples having a first unfired height; and a second longitudinal row of second staples having a second unfired height which is different than said first unfired height. 13. An end effector for stapling patient tissue, said end effector comprising: a staple cartridge comprising a proximal end and a distal end; a plurality of staples, comprising: a first longitudinal row of first staples having a first unfired height; and a second longitudinal row of second staples having a second unfired height which is different than said first unfired height; a firing system configured to implant said staples into the patient tissue; an implantable layer comprising a cartridge-facing surface; and a plurality of retainers extending above and below said cartridge-facing surface of said implantable layer which are mechanically disrupted when said firing system is actuated to implant said staples. 14. The end effector of claim 13 , further comprising a cutting member movable from said proximal end toward said distal end to transect the patient tissue. 15. The end effector of claim 13 , wherein said firing system comprises: staple supports which support said staples when said firing system is actuated; and an anvil configured to deform said staples, wherein a first distance is defined between said staple supports and said anvil prior to said firing system being actuated, and wherein a second distance is defined between said staple supports and said anvil after said firing system has been actuated which is different than said first distance.

Assignees

Inventors

Classifications

  • with separate closing member, e.g. for interlocking with staple · CPC title

  • A61B17/068Primary

    Surgical staplers {, e.g. containing multiple staples or clamps}({staplers containing only one staple A61B17/10; magazines or containers for staples A61B17/105;} for performing anastomosis A61B17/115; {staplers in general B25C5/00}) · CPC title

  • with actuating members moving in opposite directions · CPC title

  • with a frangible part, e.g. by reduced diameter · CPC title

  • Toothed members, e.g. rack and pinion · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10064624B2 cover?
An end effector for stapling patient tissue is disclosed. The end effector comprises a frame comprising a proximal end and a distal end, a plurality of staples, a firing system configured to implant the staples into the patient tissue, an implantable layer comprising a tissue-contacting surface and a support surface, and an array of securement members extending above and below the support surfa…
Who is the assignee on this patent?
Ethicon Endo Surgery Inc, Ethicon Llc
What technology area does this patent fall under?
Primary CPC classification A61B17/068. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).